Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Editorial

Asbestos mortality: a Canadian export

Amir Attaran, David R. Boyd and Matthew B. Stanbrook
CMAJ October 21, 2008 179 (9) 871-872; DOI: https://doi.org/10.1503/cmaj.081500
Amir Attaran LLB DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Boyd LLB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew B. Stanbrook MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • J. Christopher Wagner and Asbestos
    Sergei V. Jargin
    Posted on: 12 June 2015
  • Posted on: (12 June 2015)
    Page navigation anchor for J. Christopher Wagner and Asbestos
    J. Christopher Wagner and Asbestos
    • Sergei V. Jargin, researcher

    J. Christopher Wagner was the first researcher to emphasize the association between crocidolite and tremolite with malignant mesothelioma [1,2]. His research was pivotal in the introduction of the banning of crocidolite [2]. J. Christopher Wagner propagated the association of mesothelioma with crocidolite as opposed to chrysotile mainly on the basis of epidemiologic data, although it was in part contradictory to his own...

    Show More

    J. Christopher Wagner was the first researcher to emphasize the association between crocidolite and tremolite with malignant mesothelioma [1,2]. His research was pivotal in the introduction of the banning of crocidolite [2]. J. Christopher Wagner propagated the association of mesothelioma with crocidolite as opposed to chrysotile mainly on the basis of epidemiologic data, although it was in part contradictory to his own experiments [3]. The epidemiological data were from the crocidolite- exposed workers, where the relatively large number of mesothelioma cases could have been caused by the well-aimed search. Furthermore, the higher incidence of mesothelioma in crocidolite miners could have been related to the lack of control for potential differences in exposure levels [4].

    Current asbestos-related regulations are irrational: the manufacturing, importation and use are prohibited by some countries, while others continue to increase production and exports. At the same time, introduction of asbestos substitutes would not necessarily lower the health risks: some man-made fibers are more biopersistent than asbestos [5,6]. In conclusion, the "all fibers equal" approach to the asbestos- related regulations would be not only most plausible one but also compatible with the current knowledge, conflicting as it is [7,8].

    References

    1. Wagner JC. Asbestos-related cancer and the amphibole hypothesis. The first documentation of the association. Am J Public Health 1997;87(4):687- 8.

    2. McConnochie K. Chris Wagner. The Guardian, 1 July 2000

    3. Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer 1974;29(3):252-69.

    4. Stayner LT, Dankovic DA, Lemen RA. Stayner and colleagues respond. Am J Public Health 1997;87(4):688.

    5. Larsen G. Experimental data on in vitro fibre solubility. IARC Sci Publ 1989;(90):134-9.

    6. Donaldson K, Poland CA, Murphy FA, MacFarlane M, Chernova T, Schinwald A. Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences. Adv Drug Deliv Rev 2013;65(15):2078-86.

    7. Jargin SV. The anti-asbestos campaign: in search for reasonable solutions. Ukrainian Med J 2013;5(97):153-5 (in Russian).

    8.Jargin SV. Asbestos and its substitutes: International coordination and independent research needed. J Environ Occup Sci. 2015; 4(1): 1-4. doi:10.5455/jeos.20141223050627

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 179 (9)
CMAJ
Vol. 179, Issue 9
21 Oct 2008
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Asbestos mortality: a Canadian export
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Asbestos mortality: a Canadian export
Amir Attaran, David R. Boyd, Matthew B. Stanbrook
CMAJ Oct 2008, 179 (9) 871-872; DOI: 10.1503/cmaj.081500

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Asbestos mortality: a Canadian export
Amir Attaran, David R. Boyd, Matthew B. Stanbrook
CMAJ Oct 2008, 179 (9) 871-872; DOI: 10.1503/cmaj.081500
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • Asbestos panelists accuse government of misusing science
  • PubMed
  • Google Scholar

Cited By...

  • Asbestos in Canada: time to change our legacy
  • Google Scholar

More in this TOC Section

  • “Less is better” is the best message when talking to patients about alcohol
  • Nouvelle politique sur l’utilisation des outils d’intelligence artificielle dans les manuscrits soumis au JAMC
  • Without more acute care beds, hospitals are on their own to grapple with emergency department crises
Show more Éditorial

Similar Articles

Collections

  • Topics
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire